,.
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):9. doi: 10.1167/iovs.61.2.9.
Variant B precursor cysteine protease inhibitor cystatin C, a known recessive risk factor for developing exudative age-related macular degeneration (AMD), presents altered intracellular trafficking and reduced secretion from retinal pigment epithelial (RPE) cells. Because cystatin C inhibits multiple extracellular matrix (ECM)-degrading cathepsins, this study evaluated the role of this mutation in inducing ECM-related functional changes in RPE cellular behavior.
Induced pluripotent stem cells gene-edited bi-allelically by CRISPR/Cas9 to express the AMD-linked cystatin C variant were differentiated to RPE cells and assayed for their ability to degrade fluorescently labeled ECM proteins. Cellular migration and adhesion on multiple ECM proteins, differences in transepithelial resistance and polarized protein secretion were tested. Vessel formation induced by gene edited cells-conditioned media was quantified using primary human dermal microvascular epithelial cells.
Variant B cystatin C-expressing induced pluripotent stem cells-derived RPE cells displayed a significantly higher rate of laminin and fibronectin degradation 3 days after seeding on fluorescently labeled ECM (P < 0.05). Migration on matrigel, collagen IV and fibronectin was significantly faster for edited cells compared with wild-type (WT) cells. Both edited and WT cells displayed polarized secretion of cystatin C, but transepithelial resistance was lower in gene-edited cells after 6 weeks culture, with significantly lower expression of tight junction protein claudin-3. Media conditioned by gene-edited cells stimulated formation of significantly longer microvascular tubes (P < 0.05) compared with WT-conditioned media.
Reduced levels of cystatin C lead to changes in the RPE ability to degrade, adhere, and migrate supporting increased invasiveness and angiogenesis relevant for AMD pathology.
变体 B 前体半胱氨酸蛋白酶抑制剂胱抑素 C 是已知的渗出性年龄相关性黄斑变性 (AMD) 的隐性风险因素,它表现出改变的细胞内运输和从视网膜色素上皮 (RPE) 细胞中的分泌减少。由于胱抑素 C 抑制多种细胞外基质 (ECM)-降解组织蛋白酶,因此本研究评估了这种突变在诱导 RPE 细胞行为中与 ECM 相关的功能变化中的作用。
通过 CRISPR/Cas9 对诱导多能干细胞进行双等位基因编辑,表达与 AMD 相关的胱抑素 C 变体,将其分化为 RPE 细胞,并检测其降解荧光标记 ECM 蛋白的能力。测试细胞在多种 ECM 蛋白上的迁移和粘附、跨上皮电阻和极化蛋白分泌的差异。使用原代人真皮微血管上皮细胞定量检测经基因编辑细胞条件培养基诱导的血管形成。
表达变体 B 胱抑素 C 的诱导多能干细胞衍生的 RPE 细胞在荧光标记 ECM 上接种后 3 天显示出明显更高的层粘连蛋白和纤维连接蛋白降解率 (P < 0.05)。与野生型 (WT) 细胞相比,编辑细胞在基质胶、胶原蛋白 IV 和纤维连接蛋白上的迁移速度明显更快。编辑和 WT 细胞均显示出胱抑素 C 的极化分泌,但在 6 周培养后,基因编辑细胞的跨上皮电阻较低,紧密连接蛋白 Claudin-3 的表达明显降低。与 WT 条件培养基相比,基因编辑细胞的条件培养基刺激形成的微血管管明显更长 (P < 0.05)。
胱抑素 C 水平降低导致 RPE 降解、粘附和迁移能力发生变化,支持与 AMD 病理学相关的侵袭性和血管生成增加。